Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$72.4K Sell
59,856
-43,451
-42% -$76.8K ﹤0.01% 12735
2026
Q2
$195K Buy
103,307
+92,375
+845% +$190K ﹤0.01% 11977
2026
Q1
$14.8K Sell
10,932
-3,306
-23% -$6.64K ﹤0.01% 12898
2025
Q4
$37K Buy
+14,238
New +$38.9K ﹤0.01% 11840
2025
Q3
– Sell
-36,204
Closed -$146K – 12464
2025
Q2
$146K Sell
36,204
-1,878
-5% -$6.93K ﹤0.01% 11521
2025
Q1
$127K Buy
38,082
+20,174
+113% +$96.2K ﹤0.01% 11359
2024
Q4
$111K Buy
+17,908
New +$104K ﹤0.01% 11256

Other funds holding BTMD

Jeff Yass's BTMD Position: Q3 2026 in Review

Jeff Yass reduced its Biote (BTMD) stake by 42% in Q3 2026, selling an estimated $76.8K and leaving 59,856 shares worth $72.4K. The position accounts for ﹤0.01% of the portfolio, ranked #12735.

Jeff Yass first reported a position in BTMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $195K in Q2 2026. 57 funds tracked by Wall St. Rank hold BTMD as of Q3 2026.

  • Jeff Yass held 59,856 shares of Biote worth $72.4K as of Q3 2026.
  • Jeff Yass sold 43,451 Biote shares in Q3 2026, an estimated $76.8K.
  • Biote made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12735 holding.
  • Jeff Yass first reported a position in Biote in Q4 2024 and has held it in 7 quarters since.
  • Jeff Yass's Biote position peaked at $195K in Q2 2026.
  • 57 funds tracked by Wall St. Rank held Biote as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.